| Oral presentation schedule for November 3 (Thu), Day 1 |
| |
|
Kobe International Exhibition Hall No.2 Building |
Portopia Hotel |
Kobe International Conference Center |
Kobe International Exhibition Hall No.1 Building |
Kobe International Exhibition Hall No.2 Building |
|
| |
|
Hall (South) |
Conference Room 3A |
Portopia Hall |
Ohwada A |
Ohwada B |
Ohwada C |
Kairaku 1 |
Kairaku 2 |
Kairaku 3 |
Waraku |
Topaz |
Emerald |
Ikuta |
501+502 |
Digital Poster Session & Commercial Exhibition |
Digital Poster Session & Commercial Exhibition |
|
| |
|
Room 1 |
Room 2 |
Room 3 |
Room 4 |
Room 5 |
Room 6 |
Room 7 |
Room 8 |
Room 9 |
Room 10 |
Room 11 |
Room 12 |
Room 13 |
Room 14 |
Room 15 |
Room 16 |
|
| 8:00 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8:00 |
| 40 |
|
No planned seminars |
Breakfast
Seminar1 EA Pharma Co., Ltd.
Frontier of Digestive Endoscopy – Tips for Your Practice – |
|
Breakfast
Seminar2 Bayer Yakuhin, Ltd.
Progress in diagnosis and treatment of HCC |
No planned seminars |
Breakfast
Seminar3 Sumitomo Bakelite Co., Ltd.
Next step to actualize safer ESD |
No planned seminars |
Breakfast
Seminar4 Otsuka Pharmaceutical Co., Ltd.
Clinical benefit of V2 receptor antagonist |
Breakfast
Seminar5 EIKEN CHEMICAL CO., LTD.
New Development of Colorectal Cancer Screening |
No planned seminars |
No planned seminars |
Breakfast
Seminar6 Kaigen Pharma Co., Ltd.
Disinfection potential of electrolyzed strongly acidic water against Mycobacteria |
Breakfast
Seminar7 Pfizer Japan Inc.
Tips to foresee the IBD treatment from the Gut Immunity perspective |
|
|
|
40 |
| 45 |
Opening Ceremony |
45 |
| 50 |
|
|
|
|
|
|
|
|
|
|
|
|
50 |
| 9:00 |
|
9:00 |
| 30 |
|
S1 (JSGE / JGES / JSGS / JSGCS)
Gastric cancer in a post H.pylori era Chair: N. Uemura
H. Miwa |
W1 (JGES / JSGCS)
Innovation and development of capsule endoscopy Chair: S. Fukuda
K. Higuchi |
PD3 (JSH / JSGE / JSGS / JSGCS)
HCC management in the era of containing hepatitis virus Chair: H. Kumada
K. Koike |
Invited Lecture (JSH)
How ultrasound guidance impacts HCC guidelines G. Torzilli
Chair: H. Imamura |
Integrated Program 1(S) (JDDW (JGES / JSGE / JSGS))
The current status and issue of colitic cancer Chair: M. Kusunoki
Y. Suzuki
F. Hirai |
PD4 (JSGCS / JSGE / JGES)
Current status and countermeasure of population-based gastric endoscopic screening Chair: T. Kamada
K. Mabe |
W5 (JSGE / JGES / JSH / JSGS / JSGCS)
MicroRNA in digestive diseases Chair: T. Takayama
H. Marusawa |
IS-S1 (JSH / JSGE / JSGCS)
Genomics of hepatocellular carcinoma: Hepatitis virus infection and hepatocarcinogenesis Chair: H. Aburatani
Y. Asahina |
PD5 (JGES / JSGE / JSGS / JSGCS)
The roles of endoscopy for early diagnosis of pancreatic and biliary carcinoma Chair: H. Maguchi
K. Hanada |
Live broadcast
Room |
W7 (JSH / JSGE)
Autoimmune liver diseases - clinical problems to be solved Chair: A. Tanaka
H. Ohira |
Live broadcast
Room |
Live broadcast
Room |
|
|
Commercial Exhibition |
|
Commercial Exhibition |
30 |
| 40 |
| Digital Poster Session (JSGE) |
9:30 | 11:00 |
| Digital Poster Session (JSGCS) |
9:30 | 11:30 |
40 |
| 10:00 |
W3 (JSH / JSGE / JSGS / JSGCS)
The latest diagnostic imaging for liver cancer Chair: H. Iijima
M. Ogawa |
10:00 |
| 11:00 |
|
|
|
11:00 |
| 30 |
|
|
|
|
30 |
| 12:00 |
Special Lecture (JGES)
Perspectives on medical science and care in Japan T. Arakawa
Chair: A. Terano |
Lecture by Congress President (JSGCS)
Community-based colorectal cancer screening using fecal occult blood testing in combination with flexible sigmoidoscopy R. Nozaki
Chair: A. Fukao |
|
12:00 |
| 30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
| 13:00 |
Academic Council (Japanese Society of Gastroenterology)
12:30-13:40 |
Luncheon
Seminar29 Covidien Japan Inc.
UC Severity Index for Colon Capsule Endoscopy and its effectiveness –Ulcerative Colitis Capsule Endoscopic Index (UCCEI) – |
No planned seminars |
Luncheon
Seminar30 Gilead Sciences, Inc.
Challenge of DAA therapy |
Luncheon
Seminar31 Mitsubishi Tanabe Pharma Corporation
"New one to the Universal" on Ulcerative colitis Treatment |
Luncheon
Seminar32 Sumitomo Dainippon Pharma Co., Ltd. / Toray Industries, Inc. / Toray Medical Co., Ltd
Total management of chronic liver disease -Treatment satisfaction of physician and Daily life satisfaction of patients- |
Luncheon
Seminar33 Pfizer Japan Inc. / Hospira Japan Co., Ltd. / Maruishi Pharmaceutical Co., Ltd.
Safe sedation management in endoscope –The roles of a sedative; Dexmedetomidine – |
Luncheon
Seminar34 AbbVie GK
Recent trend in treatment of patients with HCV: To optimize the therapeutic efficacy using various DAAs |
Luncheon
Seminar35 TOSHIBA MEDICAL SYSTEMS CORPORATION
CT Colonography is Moving on to The Next Stage |
Luncheon
Seminar36 NIPPON KAYAKU Co., Ltd.
The significance of the drug choice for treatment of HCC -focusing anticancer agents- |
Luncheon
Seminar37 TAIHO PHARMACEUTICAL CO., LTD.
Chemotherapy for advanced colorectal cancer with oral chemothepeutic agent |
Luncheon
Seminar38 MEDICO'S HIRATA INC.
MH ERCP New Device Innovation –GW M-Through & BONASTENT M-Hilar・M-Intraductal– |
Luncheon
Seminar39 ASKA Pharmaceutical Co., Ltd.
Intestinal bacteria and Digestive system disorder |
13:00 |
| 40 |
|
|
|
|
40 |
| 14:00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
14:00 |
| 15 |
|
PD1 (JSH / JSGE)
Selection of direct acting antivirals for sustained virological response Chair: O. Yokosuka
M. Moriyama |
Special Lecture (JGES)
Therapeutic strategy of inflammatory bowel disease K. Ohtsuka
Chair: H. Hiraishi |
W2 (JSGE / JSH / JSGS / JSGCS)
Relationship between digestive diseases and metabolic disorders Chair: T. Saibara
T. Azuma |
W4 (JSH / JSGE / JSGS / JSGCS)
Current study on biomarkers in liver diseases Chair: K. Chayama
M. Honda |
Integrated Program 2(W) (JDDW (JGES / JSGS))
Collaborative surgery with endoscopy and laparoscopy Chair: T. Michida
N. Hiki |
Invited Lecture (JSGE)
Solving the puzzles of primary biliary cholangitis M. E. Gershwin
Chair: K. Okazaki |
Invited Lecture (JGES)
Functional disorder of the proximal gastrointestinal tract J. Tack
Chair: M. Kusano |
IS-W1 (JSGE / JGES / JSGS)
Recent progress in chronic pancreatitis Chair: A. K. Saluja
A. Masamune |
Report (JSGCS)
Annual report of gastrointestinal cancer screening in Japan 2014 M. Mizuguchi
Chair: T. Tsuchigame |
Live broadcast
Room |
Special Lecture (JGES)
Endoscopic diagnosis of gastrointestinal lymphomas S. Nakamura
Chair: K. Kasugai |
Live broadcast
Room |
Live broadcast
Room |
|
|
| Digital Poster Session (JSGCS) |
14:00 | 16:30 |
| Digital Poster Session (JGES) |
14:00 | 16:30 |
| Digital Poster Session (JSH) |
14:00 | 16:30 |
15 |
| 20 |
Invited Lecture (JSGCS)
National colorectal screening programmes in the UK R. J. C. Steele
Chair: H. Saito |
20 |
| 30 |
PD2 (JGES / JSGE / JSGS)
Therapeutic strategy for mucosal healing in IBD practice Chair: R. Iwakiri
N. Yoshimura |
30 |
| 40 |
W8 (JGES / JSGE)
Endoscopic characteristics of gastrointestinal lymphoproliferative disorders Chair: K. Ohnita
S. Yamamoto |
40 |
| 15:00 |
W6 (JGES / JSGE / JSGS)
The role of gastrointestinal endoscopy for diagnosis and treatment in functional gastrointestinal disorders Chair: K. Iwakiri
A. Nagahara |
15:00 |
| 10 |
|
Special Lecture (JSGE)
Study earthquakes and prepare for disaster K. Oike
Chair: T. Shimosegawa |
|
|
10 |
| 16:00 |
PD6 (JSGCS / JSGE / JGES)
Quality assurance in screening colonoscopy Chair: Y. Suzuki
T. Shimada |
16:00 |
| 30 |
|
|
|
|
30 |
| 17:00 |
|
|
17:00 |
| 30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
| 18:00 |
Satellite
Symposium63 Bristol-Myers Squibb K.K.
Endless stream of hepatitis C treatment |
Satellite
Symposium64 Astellas Pharma Inc.
The role of tacrolimus in refractory ulcerative colitis |
Satellite
Symposium65 FUJIFILM Medical Co., Ltd
What is required for safe and reliable colonoscopic diagnosis and treatment |
No planned seminars |
No planned seminars |
Setting up the JDDW Banquet Room |
Western District Council (Japan Society of Hepatology)
17:30-18:30 |
Satellite
Symposium66 DAIICHI SANKYO CO., LTD / AstraZeneca K.K.
Treatment response to reflux esophagitis and positioning of PPI in the guidelines |
Satellite
Symposium67 FUJIFILM Medical Co., Ltd
Current status and future vision on endoscopic screening of gastric cancer |
Satellite
Symposium68 Amano Enzyme Inc.
Digestive enzyme supplementation: How should the patients be treated? |
Satellite
Symposium69 Takeda Pharmaceutical Company Limited
Colorectal cancer treatment frontier |
Satellite
Symposium70 Covidien Japan Inc.
Future possibilities of Ablation |
Satellite
Symposium71 ASAHI KASEI MEDICAL CO., LTD.
Current and future advances of leukocytapheresis for ulcerative colitis |
18:00 |
| 30 |
|
|
|
|
30 |
| 40 |
|
|
|
|
40 |
| 50 |
|
50 |
| 19:00 |
Social Gathering (after the Satellite Seminar) |
19:00 |
| 30 |
|
|
|
|
|
|
|
|
|
|
30 |
| 20:00 |
|
|
|
|
|
|
20:00 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
